Randomized Control Trial of Quadratus Lumborum Block for Lumbar Spine Decompression and Fusion Surgery

NCT04447950 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-06-25

No results posted yet for this study

Summary

Lumbar spinal decompression and fusion is a commonly performed procedure fro neural impingement and back pain from a variety of pathologies. The importance of pain control in the postoperative period for spinal surgery has been discussed and proven extensively, with both immediate and delayed reduction in complications and improved clinical results.

Quadratus lumborum (QL) block was introduced in 2007 and is performed under ultrasound guidance for perioperative pain management in various surgeries.However, the plane for a posterior QL block can be easily reached during open midline spinal surgery.

The investigators hypothesize that the posterior QL block is an effective analgesic tool for lumbar laminectomy surgery, because in lumbar laminectomy the quadratus lumborum is already exposed and is in direct visual contact. For that reason it is imperative to test the benefits of this procedure.

This is a double blinded randomized control study to assess the results of intra-operative QL block performed for lumbar decompression and fusion.

Conditions

  • Spinal Stenosis Lumbar
  • Spondylolisthesis
  • Fusion of Spine, Lumbar Region
  • Degeneration Spine

Interventions

PROCEDURE

Type 2/posterior Quadratus Lumborum block

Injection of local anaesthetic into posterior boundry of Quadratus Lumborum muscle.

PROCEDURE

Placebo block with Saline

Injection of saline into posterior boundary of Quadratus Lumborum muscle.

Sponsors & Collaborators

  • Assuta Medical Center

    lead OTHER

Principal Investigators

  • Ely Ashkenazy, MD · Neurosurgeon, Assuta medical center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-30
Primary Completion
2021-05-31
Completion
2021-08-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04447950 on ClinicalTrials.gov